http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E8%83%B6%E8%B4%A8%E7%98%A4-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-CD105-MVD 2026-06-17T08:59:01Z 本wiki的该页面的版本历史 MediaWiki 1.30.0 http://120.24.161.253:5617/index.php?title=%E8%83%B6%E8%B4%A8%E7%98%A4-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-CD105-MVD&diff=1762250&oldid=prev 2024-07-06T14:00:00Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 14:00的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E8%83%B6%E8%B4%A8%E7%98%A4-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-CD105-MVD&diff=1762251&oldid=prev 2024-07-06T13:03:37Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 13:03的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l10" >第10行：</td> <td colspan="2" class="diff-lineno">第10行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===CEACAM1和VEGF在人脑胶质瘤中的表达及其与肿瘤血管生成的关系（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===CEACAM1和VEGF在人脑胶质瘤中的表达及其与肿瘤血管生成的关系（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>CEACAM1和VEGF标记指数及[[CD105-MVD]]与[[胶质瘤]]病理分级密切相关(P<del class="diffchange diffchange-inline">&lt;</del>0.01),CEACAM1、VEGF标记指数均与[[CD105-MVD]]均呈显著正相关(r分别为0.889和 0.803,均P<del class="diffchange diffchange-inline">&lt;</del>0.01),且CEACAM1与VEGF亦呈正相关(r</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>CEACAM1和VEGF标记指数及[[CD105-MVD]]与[[胶质瘤]]病理分级密切相关(P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.01),CEACAM1、VEGF标记指数均与[[CD105-MVD]]均呈显著正相关(r分别为0.889和 0.803,均P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.01),且CEACAM1与VEGF亦呈正相关(r</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===胶质瘤中CD105与VEGF、Ki-67表达的相关性（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===胶质瘤中CD105与VEGF、Ki-67表达的相关性（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>结论 [[胶质瘤]]中[[CD105-MVD]]与VEGF阳性细胞百分率、Ki-67 LI均有显著相关性,提示其可作为判断[[胶质瘤]]恶性程度的指标.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>结论 [[胶质瘤]]中[[CD105-MVD]]与VEGF阳性细胞百分率、Ki-67 LI均有显著相关性,提示其可作为判断[[胶质瘤]]恶性程度的指标.</div></td></tr> </table>

KGadmin http://120.24.161.253:5617/index.php?title=%E8%83%B6%E8%B4%A8%E7%98%A4-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-CD105-MVD&diff=547257&oldid=prev 2021-11-22T13:12:11Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2021年11月22日 (一) 13:12的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E8%83%B6%E8%B4%A8%E7%98%A4-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-CD105-MVD&diff=547250&oldid=prev 2021-10-19T13:56:59Z

<p>修改1</p> <p><b>新页面</b></p><div>主实体：[[胶质瘤]]，关系：[[实验室检查]] ，尾实体：[[CD105-MVD]]<br /> <br /> 实体ID:''613126''<br /> ==关系介绍==<br /> 待补充<br /> <br /> ==来源==<br /> ===人脑胶质瘤血管生成与基质细胞衍生因子-1α表达的相关性（中华医学会文献）===<br /> SDF-1α标记指数及[[CD105-MVD]]与[[胶质瘤]]病理分级密切相关(P＜0.01),SDF-1α标记指数与CD105 -MVD均呈正相关(r=0.872,P＜0.01).<br /> <br /> ===CEACAM1和VEGF在人脑胶质瘤中的表达及其与肿瘤血管生成的关系（中华医学会文献）===<br /> CEACAM1和VEGF标记指数及[[CD105-MVD]]与[[胶质瘤]]病理分级密切相关(P&lt;0.01),CEACAM1、VEGF标记指数均与[[CD105-MVD]]均呈显著正相关(r分别为0.889和 0.803,均P&lt;0.01),且CEACAM1与VEGF亦呈正相关(r<br /> <br /> ===胶质瘤中CD105与VEGF、Ki-67表达的相关性（中华医学会文献）===<br /> 结论 [[胶质瘤]]中[[CD105-MVD]]与VEGF阳性细胞百分率、Ki-67 LI均有显著相关性,提示其可作为判断[[胶质瘤]]恶性程度的指标.</div>

Admin